Enhancing Diagnostic Accuracy of aMCI in the Elderly: Combination of Olfactory Test, Pupillary Response Test, BDNF Plasma Level, and APOE Genotype

Background. Amnestic Mild Cognitive Impairment (aMCI) often progresses to Alzheimer's disease. There are clinical markers and biomarkers to identify the degenerative process in the brain. Objectives. To obtain the diagnostic values of olfactory test, pupillary response to tropicamide 0.01%, BDN...

Descripción completa

Detalles Bibliográficos
Autores principales: Turana, Yuda, Ranakusuma, Teguh Asaat S., Purba, Jan Sudir, Amir, Nurmiati, Ahmad, Siti Airiza, Machfoed, Moh. Hasan, Handayani, Yvonne Suzy, Asmarinah, Waspadji, Sarwono
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929508/
https://www.ncbi.nlm.nih.gov/pubmed/24639912
http://dx.doi.org/10.1155/2014/912586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929508/
https://www.ncbi.nlm.nih.gov/pubmed/24639912
http://dx.doi.org/10.1155/2014/912586

Ejemplares similares